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JOURNAL OF HEPATOLOGYLactobacillus johnsonii La1 without antioxidants does not
decrease bacterial translocation in rats with carbon
tetrachloride-induced cirrhosisTo the Editor:
We read with interest the recent paper by Fouts et al. [1] showing
that bacterial translocation occurs not only in rats with advanced
CCl4-induced cirrhosis but also in rats with early stages of liver
injury. Furthermore, the authors suggest that bacterial transloca-
tion, mainly in these early stages, is due to increased intestinal
permeability more than to changes in the intestinal microbiome.
As probiotics can improve intestinal permeability and modulate
gut ﬂora [2], there is increasing interest in their possible efﬁcacy
to prevent bacterial translocation, and therefore, progression of
liver damage and bacterial infections in liver diseases [2–5].
In a previous article published in the Journal of Hepatology [6],
we found that a combination of the probiotic Lactobacillus
johnsonii La1, vitamin C and glutamate decreased Gram-negative
intestinal bacterial overgrowth, bacterial translocation, and
intestinal oxidative damage in rats with cirrhosis induced by phe-
nobarbital and CCl4 administration. Similar results were obtained
when rats received vitamin C and glutamate without L. johnsonii
La1. However, as L. johnsonii La1 was not administered alone, the
speciﬁc contribution of this probiotic could not be assessed in the
previous study.
To determine the effect of L. johnsonii La1 on intestinal bacte-
rial ﬂora and bacterial translocation, we have recently studied 18
male Sprague–Dawley rats with cirrhosis induced by phenobarbi-
tal and CCl4 through gastric intubation according to a previously
described method [7]. When the rats developed ascites conﬁrmed
by paracentesis, they were randomized to receive L. johnsonii La1
alone, 109 cfu/day by gastric intubation (n = 9) for 10 days, or
water (n = 9). At laparotomy, we found no statistically signiﬁcant
differences between the two groups in the concentration of ileal
enterobacteria (3.62 ± 0.29 vs. 4.43 ± 0.35 log10cfu/g feces,
p = 0.07) or in the incidence of bacterial translocation assessed
by microbiological cultures of mesenteric lymph nodes, ascites,
or pleural ﬂuid (4/9 vs. 4/9, p = 1). Neither were differences
observed between the two groups regarding intestinal oxidative
damage, evaluated by the ileal malondialdehyde concentration
(0.82 ± 0.32 vs. 0.74 ± 0.21 nmol/mg protein, p = 0.90). The PCR
reaction with speciﬁc primers for L. johnsonii La1 (oNCC2461-A
and oNCC2461-B) failed to show intestinal colonization in the
feces of rats treated with this bacterium.
These ﬁndings thus indicate that L. johnsonii La1 alone has no
signiﬁcant effect on intestinal ﬂora and bacterial translocation in
this experimental model of cirrhosis. Other studies evaluating
Lactobacillus acidophilus and Lactobacillus casei GG in experimen-
tal prehepatic portal hypertension [3], and Lactobacillus rhamno-Journal of Hepatology 201sus GG in rats with CCl4-induced cirrhosis [4] have reported
similar results. The present data suggest that the beneﬁcial
effects observed in our previous study were mainly due to the
antioxidant effect of vitamin C and glutamate. Oxidative damage
in the intestinal wall seems to play a relevant role in the gut bar-
rier failure leading to bacterial translocation in several experi-
mental models of cirrhosis and portal hypertension [8,9]. The
antioxidant effect of vitamin C and glutamate could have
improved intestinal motility and gut permeability, and both these
mechanisms would explain the decrease in intestinal bacterial
overgrowth and bacterial translocation observed in our previous
study [8–10].
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An unusual risk factor for intrahepatic cholangiocarcinoma
To the Editor:
In the July 2012 issue of the Journal of Hepatology, on the basis of
the meta-analysis of 11 studies, Palmer and Patel [1] reported
that hepatocellular carcinoma (HCC) and intrahepatic cholangio-
carcinoma (ICC) share common risk factors of tumour develop-
ment, such as cirrhosis and chronic viral hepatitis. These
ﬁndings may support the hypothesis that both HCC and ICC are
derived from hepatic progenitor cells, and may explain the path-
ogenesis of combined hepatocellular and cholangiocellular carci-
noma. In the report, extrahepatic cholangiocarcinoma (ECC) was
excluded from the analysis because the clinicopathological fea-
tures of ECC were different from ICC, and the speciﬁc risk factors
for ICC, such as primary sclerosing cholangitis, hepatolithiasis,
and biliary malformations were not within the scope of the
analysis.
At the annual meeting of the Japan Society for Occupational
Medicine held on May 31, 2012, Shinji Kumagai and colleagues
reported ﬁve cases with cholangiocarcinoma among 40 workers
at a printing company in Osaka, Japan [2]. Kumagai and col-
leagues estimated that the incidence of cholangiocarcinoma
among employees of the printing company was about 600 times
higher than the national average, which raised the discussion
about health hazards caused by chemicals. Soon after the report
by Kumagai and colleagues, seven additional employees who
had worked at the printing ﬁrm between 1991 and 2003 were
identiﬁed and presented with cholangiocarcinoma. Seven out of
12 employees with cholangiocarcinoma died at the average age
of 37, being about half the national average age of death from
cholangiocarcinoma [3–5]. On July 11, 2012, the Health, Labor
and Welfare Ministry in Japan stated that a total of 17 cholangi-
ocarcinoma patients with a mortality rate of 47% were identiﬁed
from former and current workers of printing companies across
Japan [6–7]. Of the ﬁrst ﬁve cholangiocarcinomas found at a
printing company, four were ICCs [8], while details about the
remaining cases have not been elucidated. Exposure to large
amounts of volatile organic compounds, such as methylene chlo-
ride (dichloromethane), dichloropropane, and ethylene chloride,
without adequate ventilation is assumed to be responsible for
the development of cholangiocarcinoma in the printing ﬁrm [6–
7]. These organic compounds are solved in cleansers to wash
ink off of printing machines. More than 20 years ago, excess mor-
tality from liver and biliary tract cancer among cellulose ﬁber
production workers in the Unites States was reported [9]. Since
during the cellulose triacetate production process, employees
were mainly exposed to the solvent methylene chloride, the asso-
ciation between methylene chloride exposure and development
of liver and biliary tract cancer was suggested. Further, women
from bookprinting and offset printing industries in Denmark
had an odds ratio of developing liver cancer (HCC, ICC, and com-
bined carcinoma) in excess of 10.0 [10]. However, according to a
36.8-year follow-up of 1473 workers, exposed to methylene chlo-
ride on average for 9 years at a concentration of 19 ppm, at a
plant producing cellulose triacetate ﬁlm base, methylene chloride
exposure was not associated with any cancer death [11]. The data
collected at printing companies in Japan and genetic polymor-
phisms of the glutathione pathway involved in the metabolism
of organic compounds suggest that inhalation of organic com-
pounds may be a risk factor for ICC in a population, when expo-
sure exceeds a threshold dose.
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